trihexyphenidyl has been researched along with Benign Infantile Myoclonic Epilepsy in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myoclonic dystonia is a rare disorder that occurs in an hereditary and a sporadic form." | 1.28 | Myoclonic dystonia. ( Friedman, JH; Pueschel, SM; Shetty, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pueschel, SM | 1 |
| Friedman, JH | 1 |
| Shetty, T | 1 |
1 other study available for trihexyphenidyl and Benign Infantile Myoclonic Epilepsy
| Article | Year |
|---|---|
Myoclonic dystonia.
Topics: Adult; Biopsy; Cerebellum; Diseases in Twins; Drug Therapy, Combination; Dystonia; Epilepsies, Myocl | 1992 |